(Q39713565)

14 September 2017

Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis (English)

1 reference

14 September 2017

0 references

Gian D van der Spuy

5

0 references

Robin M. Warren

object named as

Robin M Warren

2

0 references

Nulda Beyers

3

object named as

Nulda Beyers

1 reference

14 September 2017

7

Donald A Enarson

1 reference

14 September 2017

9

Paul D van Helden

1 reference

14 September 2017

6

Martien W Borgdorff

1 reference

14 September 2017

Suzanne Verver

1

1 reference

14 September 2017

Madalene Richardson

4

1 reference

14 September 2017

Marcel A Behr

8

1 reference

14 September 2017

language of work or name

English

0 references

publication date

14 April 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

14 September 2017

1 reference

14 September 2017

171

1 reference

14 September 2017

12

1 reference

14 September 2017

1430-1435

1 reference

A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes

14 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Recurrence in tuberculosis: relapse or reinfection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Tuberculosis recurrences: reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Molecular Epidemiology of Tuberculosis among HIV-Infected Persons in Switzerland: A Countrywide 9-Year Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Recurrent tuberculosis in the United States and Canada: relapse or reinfection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

DNA fingerprint changes in tuberculosis: reinfection, evolution, or laboratory error?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Transmission of tuberculosis in a high incidence urban community in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Proportion of tuberculosis transmission that takes place in households in a high-incidence area

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Patients with active tuberculosis often have different strains in the same sputum specimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Genetics and resistance to tuberculosis. Could resistance be enhanced by genetic engineering?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

Molecular epidemiology of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200409-1200OC

10.1164/RCCM.200409-1200OC

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference